Health X Platform Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026.

Date: 06-11-2026 To To The General Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Mumbai - 400 051 Ref: BSE Scrip Code: 533259; NSE Symbol: HEALTHX Sub: Intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 - Notice of Board Meeting Dear Sir/ Madam, Notice is hereby given, pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company will be held on Saturday, the 14th November, 2026 inter-alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026. Further, in continuation to our disclosure made on Closure of Trading Window dated 25th September, 2026 we further inform that the trading window of the Company for dealing in securities of the Company shall remain closed till 48 hours after the declaration of the aforesaid Financial Results of the Company to the Stock Exchanges. This is for your information and record. Thanking you, Yours faithfully, For Health X Platform Limited (formerly known as Sastasundar Ventures Limited) Pratap Singh Company Secretary & Compliance Officer M. No.: A24081